Delta Opioid Agonists Inhibit Proliferation of Highlypurified Murine CD4+ and CD8+ T-Cells

  • N. A. Shahabi
  • B. M. Sharp
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 373)


A substantial body of evidence demonstrates that opiates and opioid peptides modulate immune function. The present study used highly purified murine CD4+ and CD8+ T-cells to determine the effects of delta opioid receptor (DOR) agonists on proliferation. Splenic T-cells, obtained from male or female C57BL/6 or CD1 mice, were separated by a fluorescence activated cell sorter. Cells were stimulated to proliferate in serum free medium by cross-linking the T-cell receptor using plate-coated anti-CD3-ε; 3H-thymidine uptake was determined at 48 hours. Previous experiments had shown that deltorphin and [D-A1a2]-met-enkephalinamide (DAME), at concentrations from 10-11 to 10-7 M, dose dependently inhibited the proliferation of CD4+ and CD8+ T-cells obtained from female C57BL/6 or CD1 mice. Similarly, the experiments herein demonstrate that proliferation of CD4+ T-cells from female CD1 mice was inhibited by 2,5 DPDP-enkephalin (DPDP-E), in direct relation to dose. In contrast, the anti-proliferative response of cells from C57BL/6 mice demonstrated an inverse relationship to dose. At 10-11 M, the most effective dose of DPDP-E studied, 3Hthymidine uptake was inhibited by 50%. The selective DOR antagonist, naltrindole (10-12 M), abolished this. DAME was used to compare the effects of DOR agonists on CD8+ T-cells from both strains of female mice. 3H-Thymidine uptake was dose-dependently inhibited to a similar degree in both strains; 10-7 M DAME maximally reduced proliferation by 70%. DAME had similar effects on both CD8+ and CD4+ T-cells from male mice, and its inhibitory effect was markedly attenuated after 72 hours. In summary, the dose-response profiles for the anti-proliferative effects of DAME and deltorphin are similar in CD1 and C57BL/6 mice, whereas the profiles are distinctively different for DPDP-E. The effects of DPDP-E appear to be mediated through a δ-like opiate receptor.


Morphine Polypeptide Pyruvate Methionine Leucine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wybran, J., Appelboom, T., Famaey, J.-P. and Govaerts, A: Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123: 1068–1070, 1979.PubMedGoogle Scholar
  2. 2.
    Peterson, P.K., Sharp, B.M., Gekker, G., Brummitt, C. and Keane, W.F.: Opioid-mediated suppression of interferon-7 production by cultured peripheral blood mononuclear cells. J Clin Invest 80: 824–831, 1986.CrossRefGoogle Scholar
  3. 3.
    Bessler, H., Sztein, M.B. and Serrate, S.A.: β-Endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 19: 4–14, 1990.CrossRefGoogle Scholar
  4. 4.
    Gilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E. and Feldman, J.D.: β-Endorphin enhances lymphocyte proliferative response. Proc Natl Acad Sci USA 79: 4226–30, 1982.PubMedCrossRefGoogle Scholar
  5. 5.
    Gilmore, W., Moloney, M. and Bernstein, T.: The enhancement of polyclonal T cell proliferation by beta-endorphin. Brain Res Bull 24: 687–692, 1990.PubMedCrossRefGoogle Scholar
  6. 6.
    Shahabi, N.A., Burtness M.Z., Sharp, B.M.: N-acetyl-β-endorphin antagonizes the suppressive effect of β-endorphin1–31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem Biophys Res Commun 175: 936–942, 1991.PubMedCrossRefGoogle Scholar
  7. 7.
    Hemmick, L.M. and Bidlack, J.M.: β-Endorphin modulation of mitogen-stimulated calcium uptake by rat thymoctes. Life Sci 41: 1971–8, 1987.PubMedCrossRefGoogle Scholar
  8. 8.
    Gilmore, W. and Weiner, L.P.: β-Endorphin enhances interleukin-2 (IL-2) production in murine lymphocytes. J. Neuroimmunology, 18: 125–138, 1988.CrossRefGoogle Scholar
  9. 9.
    Brown, S.L. and Van Epps, D.E.: Opioid peptides modulate production of interferon-gamma by human mononuclear cells. Cell Immunol. 103: 19–26, 1986.PubMedCrossRefGoogle Scholar
  10. 10.
    Shahabi, N.A., Linner K.M. and Sharp, B.M.: Murine splenocytes express a naloxone-insensitive binding site for β-endrophin. Endocrinology 126: 1442–1448, 1990a.CrossRefGoogle Scholar
  11. 11.
    Shahabi, N.A., Peterson, P.K. and Sharp, B.M.: β-endorphin binding to naloxone-insensitive sites on human mononuclear cell line (U937): Effect of cations and guanosine triphosphate. Endocrinology 126: 3006–3016, 1990bCrossRefGoogle Scholar
  12. 12.
    Faith, R.E., Murgo, A.J., Clinkscales, C.W. and Plotnikoff, N.P.: Enhancement of host resistance to viral and tumor challenge by treatment with methionine-enkephalin. Ann NY Acad Sci 496: 137–143. 1987.PubMedCrossRefGoogle Scholar
  13. 13.
    Oleson, D.R. and Johnson, D.R.: Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 2: 171–186, 1988.PubMedCrossRefGoogle Scholar
  14. 14.
    Rowland, R.R.R., Chukwuocha, R. and Tokuda, S.: Modulation of the in vitro murine immune response by met-enkephalin. Brain Behav Immun 1: 342–348, 1987.PubMedCrossRefGoogle Scholar
  15. 15.
    Leo, O., Foo, M., Sachs, D., Samelson, L. and Bluestone, J.: Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84: 1374–8, 1987.PubMedCrossRefGoogle Scholar
  16. 16.
    Shahabi, N.A. and Sharp, B.M.: Anti-proliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T-cells. J.Pharm. Exp. Then, in press, 1995.Google Scholar
  17. 17.
    Portoghese, P.S., Sultana, M. and Takemori, A.E.: Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.Eur. J. Pharmacol. 146: 185–186, 1988.PubMedCrossRefGoogle Scholar
  18. 18.
    Caroleo, M.C., Arbitrio, M., Melchiorri, D. and Nistico, G.: A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity. Neuroimmunomodul 1: 141–147, 1994.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • N. A. Shahabi
    • 1
  • B. M. Sharp
    • 1
  1. 1.Endocrine-Neuroscience Research Laboratory, Minneapolis Medical Research Foundation and Departments of MedicineHennepin County Medical Center and the University of MinnesotaMinneapolisUSA

Personalised recommendations